New drug trial targets lung cancer that spreads to the brain
Disease control
Recruiting now
This study is testing a drug called zorifertinib as a first treatment for people with advanced lung cancer that has spread to the brain or spinal fluid. It will compare how well zorifertinib works and how safe it is compared to other standard treatments. The goal is to see if it …
Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC